Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USA.
Methods Mol Biol. 2021;2193:85-96. doi: 10.1007/978-1-0716-0845-6_9.
Lymphangiogenesis, the formation of lymphatic vessels from preexisting ones, is an important process in wound-healing physiology. Deregulation of lymphangiogenesis and lymphatic vascular remodeling have been implicated in a range of inflammatory conditions, such as lymphedema, lymphadenopathy, tumor growth, and cancer metastasis. Any attempt in understanding various parameters of the lymphangiogenic process and developing desirable therapeutic targets requires recapitulating these conditions in in vivo models. One pitfall with some experimental models is the absence of immune response, an important regulatory factor for lymphangiogenesis. We overcome this issue by using immune competent mice. In this chapter, by using Angiopoietin-2 (Ang2), a protein that belongs to the Ang/Tie signaling pathway, we describe the ear sponge assay with important adaptations, highlighting a reproducible and quantitative tool for assessment of in vivo lymphangiogenesis.
淋巴管生成,即从先前存在的血管生成新的淋巴管,是伤口愈合生理过程中的一个重要过程。淋巴管生成和淋巴管血管重塑的失调与一系列炎症状态有关,如淋巴水肿、淋巴结病、肿瘤生长和癌症转移。要理解淋巴管生成过程的各种参数并开发理想的治疗靶点,就需要在体内模型中重现这些情况。一些实验模型的一个缺陷是缺乏免疫反应,这是淋巴管生成的一个重要调节因素。我们通过使用免疫功能正常的小鼠克服了这个问题。在这一章中,我们使用血管生成素 2(Ang2),一种属于 Ang/Tie 信号通路的蛋白质,描述了经过重要改良的耳部海绵检测实验,该实验强调了一种可重现和定量的体内淋巴管生成评估工具。